(Q36223647)

12 August 2017

Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study (English)

1 reference

12 August 2017

0 references

Andrea King

1

1 reference

12 August 2017

Dingcai Cao

series ordinal

2

1 reference

12 August 2017

Catherine Vanier

series ordinal

3

1 reference

12 August 2017

Tracie Wilcox

series ordinal

4

1 reference

12 August 2017

19 March 2009

1 reference

Alcoholism: Clinical and Experimental Research

12 August 2017

1 reference

12 August 2017

33

1 reference

12 August 2017

6

1 reference

12 August 2017

1044-1050

1 reference

Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Opioid antagonists for smoking cessation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Tobacco chippers show robust increases in smoking urge after alcohol consumption

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

The role of biomarkers in alcoholism medication trials

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

A risk-benefit assessment of naltrexone in the treatment of alcohol dependence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Naltrexone in the treatment of alcohol dependence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Effects of naltrexone on alcohol self-administration in heavy drinkers.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Naltrexone increases the latency to drink alcohol in social drinkers.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Effect of naltrexone on alcohol "high" in alcoholics.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Reliability of alcohol abusers' self-reports of drinking behavior

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Measures of abstinence in clinical trials: issues and recommendations

29 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2009.00925.X

Experience of a "slip" among alcoholics treated with naltrexone or placebo.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2009.00925.X

Naltrexone-induced alterations in human ethanol intoxication.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2009.00925.X

The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Differential effects of nicotine on alcohol consumption in men and women.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Alcohol dose-dependent increases in smoking urge in light smokers

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Naltrexone treatment for alcoholics: effect on cigarette smoking rates

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Body weight, alcohol consumption and liver enzyme activity--a 4-year follow-up study.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Naltrexone biotransformation and incidence of subjective side effects: a preliminary study.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Slip-ups and relapse in attempts to quit smoking

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Opioid antagonists for alcohol dependence

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625790

Naltrexone and alcohol dependence. Role of subject compliance

21 October 2018

1 reference

12 December 2020

Naltrexone effects on short-term and long-term smoking cessation

1 reference

12 December 2020

First lapses to smoking: within-subjects analysis of real-time reports

1 reference

12 December 2020

High-dose naltrexone therapy and dietary counseling for obesity

1 reference

12 December 2020

10.1111/J.1530-0277.2009.00925.X

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

19302083

1 reference